What we did

We soon identified a potential deal with the French veterinary company Ceva – thanks to previous connections, we knew that its equine product range was likely considered non-core. The acquisition chimed perfectly with Audevard’s growth strategy and we reached a smooth and successful outcome within the timeframe.

Capitalmind Investec supported Audevard Laboratories at every stage of the acquisition process: from the first preliminary talks with Ceva to the valuation, structuring, preparation, due diligence, execution and assistance in the final contract negotiations, including value maximization.